moderate to severe pain

Trials

60 participants · First posted Mar 23, 2021

Terminated

NCT03959852

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

6 participants · First posted May 22, 2019

Not yet recruiting

NCT07523321

Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery

274 participants · First posted Apr 13, 2026

Drugs

View all 2525 →

Small Molecule

Approved

Pentazocine

Manufacturer: Sanofi aventis us llc, Hospira inc

Conditions: Mild pain, Severe Pain +1 more

C₁₉H₂₇NO · Rx

Small Molecule

Approved

Opium

Conditions: Severe Diarrhea

Rx

Small Molecule

Approved

Anileridine

Manufacturer: Merck and co inc

C₂₂H₂₈N₂O₂

Organizations

View all 714 →

PAIN THERAPEUTICS

United States

PINNACLE PAIN MEDICINE

United States

Kineta Chronic Pain LLC

United States

News

View all 40848 →

last year

FDA Approves XIFYRM Injectable Meloxicam for Moderate-to-Severe Pain Management

5 months ago

Hope Medicine Initiates Phase III Trial for First-in-Class Non-Hormonal Endometriosis Treatment

last year

Trials

HR021618 in Moderate to Severe Pain After Abdominal Surgery

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery

Drugs

Pentazocine

Opium

Anileridine

Organizations

PAIN THERAPEUTICS

PINNACLE PAIN MEDICINE

Kineta Chronic Pain LLC

News

FDA Approves XIFYRM Injectable Meloxicam for Moderate-to-Severe Pain Management

Hope Medicine Initiates Phase III Trial for First-in-Class Non-Hormonal Endometriosis Treatment

Pain Neuroscience Education Shows Promise in Reducing Post-Operative Pain After Laparoscopic Hernia Repair